DCF — ST. LUKES PATIENTS MEDICAL CENTER
Enterprise Value: $-109.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-109.9M
Enterprise Value
$-34.9M
PV of Cash Flows
$-74.9M
PV of Terminal Value
$-120.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $74.3M | $-6.7M | -9.0% | $-9.9M | $-9.0M |
| Year 2 | $76.5M | $-6.2M | -8.0% | $-9.4M | $-7.8M |
| Year 3 | $78.8M | $-5.6M | -7.0% | $-8.9M | $-6.7M |
| Year 4 | $81.2M | $-5.3M | -7.0% | $-8.8M | $-6.0M |
| Year 5 | $83.6M | $-5.3M | -6.0% | $-8.8M | $-5.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-109.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$72.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09574806430143588
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5